Share Twitter LinkedIn Facebook Email Shyamala Maheswaran, Ph.D. from Massachusetts General Hospital speaks about the SABCS Presentation – Single Cell Analysis Of Circulating Tumor Cells.
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read
Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from SABCS with Virginia Kaklamani, MD Breast 3 Mins Read